Press Release
Sep 12, 2021
Chris Martin, IASLC Media Relations | cmartin@davidjamesgroup.com | 630.670.2745
What: The International Association for the Study of Lung Cancer (IASLC) 2021 World Conference on Lung Cancer Press Briefing
When: Sunday, September 12, 2021, 9 a.m.GMT/10 a.m. CDT/11 a.m. EDT
About: Each IASLC World Conference on Lung Cancer highlights the best in lung cancer research. Like the previous two meetings, this conference will be virtual. Each press briefing will be moderated by an IASLC member and include an IASLC Patient Research Advocate, to provide a unique perspective on how research may affect patients coping with lung cancer.
Zoom link: https://us02web.zoom.us/j/89432596247
Moderator: Anne-Marie Baird, BSc, PhD
Panelists:
Boris Sepesi, MD
OA13.01: S1619 A trial of neoadjuvant cisplatin-pemetrexed with atezolizumab in combination and maintenance for resectable pleural mesothelioma.
Anne-Marie Baird, BSc,PhD
OA17.04: The global impact of COVID-19 on telemedicine and care for persons with thoracic cancers.
Estelamar Rodriguez, MD, MPH
OA13.02: Socioeconomic Disparities in Access to Treatment and Survival in Operable Malignant Pleural Mesothelioma in the United States.
Oscar Arrieta, MD, MSc
OA17.03: Depression, Anxiety, and Distress Impact in Patients With Thoracic Malignancies During the COVID-19 Pandemic.
Shani Shiloh
Patient Research Advocate
- Press briefings will be conducted via Zoom and recordings will be sent after the briefing concludes.
- Embargoes: abstracts that are part of the press program will be embargoed for beginning of each day’s press briefing. The IASLC reserves the right to change an embargo to account for a journal publication or other issues.
- Media Registration: If you have not registered to cover the meeting, visit https://wclc2021.iaslc.org/.